Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials Academic Article uri icon

  •  
  • Overview
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Haaland, Derek Allan
  • Clowse, Megan EB
  • Wallace, Daniel J
  • Furie, Richard A
  • Petri, Michelle A
  • Pike, Marilyn C
  • Leszczyński, Piotr
  • Neuwelt, C Michael
  • Hobbs, Kathryn
  • Keiserman, Mauro
  • Duca, Liliana
  • Kalunian, Kenneth C
  • Galateanu, Catrinel
  • Bongardt, Sabine
  • Stach, Christian
  • Beaudot, Carolyn
  • Kilgallen, Brian
  • Gordon, Caroline

publication date

  • February 2017